- Home
- BFRI
BFRI
Biofrontera Inc.
as 05-16-2025 4:00pm EST
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
| Founded: | 1997 | Country: | United States |
| Employees: | N/A | City: | WOBURN |
| Market Cap: | 7.5M | IPO Year: | 2021 |
| Target Price: | $7.00 | AVG Volume (30 days): | 163.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.65 - $2.22 | Next Earning Date: | 05-15-2025 |
| Revenue: | $37,321,000 | Revenue Growth: | 9.54% |
| Revenue Growth (this year): | 18.57% | Revenue Growth (next year): | 20.17% |
Latest Biofrontera Inc. News
BFRI Breaking Stock News: Dive into BFRI Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
4 days ago
Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
ACCESS Newswire
13 days ago
Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025
GlobeNewswire
18 days ago
Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis
Simply Wall St.
2 months ago
Biofrontera Full Year 2024 Earnings: Misses Expectations
GuruFocus.com
2 months ago
Biofrontera Inc (BFRI) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amidst Financial ...
Thomson Reuters StreetEvents
2 months ago
Q4 2024 Biofrontera Inc Earnings Call
GlobeNewswire
2 months ago
Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update
Compare BFRI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BFRI Biofrontera Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.